Examples of using Interim analysis in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Interim analysis is being carried out.
The trial was stopped for futility after an interim analysis.
Interim Analysis of Controlled Clinical Trials- Breaking with a Taboo?
Table 3:Secondary efficacy endpoints from the phase III ALSYMPCA study interim analysis.
An interim analysis was performed with a median follow up of 55 months.
The study was terminated early for safety reasons after interim analysis of data from 51 patients.
This interim analysis showed a TTP risk reduction of 45%(95% CI; 29-57%), p< 0.0001.
Results from this analysis were consistent with those from the interim analysis Table 2, Figure 1.
Results: The interim analysis includes 43 subjects who have completed the 12 month follow up visit.
An objective response was observed for four of six evaluable adolescent in an interim analysis of Study 5.
The study was un-blinded after this planned interim analysis of OS had crossed the pre-specified efficacy boundary.
Joint interim analysis of two large phase III clinical trials provides first positive data of a targeted therapy after initial surgery.
The vaccine efficacy against B-CAP observed at the interim analysis is presented below table 2.
The interim analysis had not shown any clear correlation between the average quartz content of the dusts at the 20 collieries and the radiological results.
While no analysis of 30% and 50% responders at 10 and15 minutes was conducted in the interim analysis, this analysis was requested from the sponsor in the final clinical study report.
An event-driven interim analysis is expected to occur in Q4 2019 following a longer than expected duration of response in the overall patient population.
The efficacy data from this pivotal study are supported andconfirmed with data from a dose-finding study(25 mg/kg arm) and the interim analysis of an ongoing Treatment IND study(severe VOD subset), as presented in Table 1 and 2.
Of some relevance is the interim analysis data from the ongoing case-control study of the progestogen releasing contraceptive IUD(Mirena) ICPE meeting report, 2008.
The interim analysis of the data, which was recently confirmed by independent experts, shows that sorafenib significantly lengthens progression-free survival in patients with this type of cancer.
Demographic and baseline disease characteristics(interim analysis population) were similar between the Xofigo and placebo groups and are shown below for Xofigo: the mean age of patients was 70 years range 49 to 90 years.
An interim analysis showed there was a significant prolongation of the time to progression of disease in the 10 mg/ kg group as compared with the placebo group hazard ratio, 2.55; p< 0.001.
The 180/ 1.3 arm was stopped after an interim analysis, as prespecified in the protocol, when the two active-treatment arms appeared to have a similar incidence of bleeding.
Interim analysis of the study“ Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial”(ALLHAT) shows that patients with hypertension and at least one other clinical risk factor for coronary heart disease treated with doxazosin are exposed to a doubled risk for chronic heart failure compared to patients treated with chlortalidone.
In a still ongoing trial, an interim analysis showed similar results in 123 patients who had uncontrolled bleeding or required emergency surgery while using Pradaxa.
This interim analysis showed a TTP risk reduction of 45%(95% CI; 29-57%, p< 0.0001) for patients treated with combination therapy of bortezomib and pegylated liposomal doxorubicin.
Lung transplantation The interim analysis of a recent multicentre study discussed 110 patients who underwent 1:1 randomisation to either tacrolimus or ciclosporin.
After the interim analysis of efficacy and safety, at recommendation of the Independent DSMB, the study was unblinded and patients on the placebo arm were offered open-label sunitinib treatment.
The protocol pre-specified interim analysis after 520 deaths showed a statistically significant superiority in overall survival in patients treated with enzalutamide compared to placebo Table 3 and Figures 4 and 5.
The study was halted as the interim analysis(N=475) showed a low incidence of CNS events and, superior efficacy of the trastuzumab plus capecitabine arm in terms of progression-free survival and overall survival see results of final analysis in Table 3.
Methods: The interim analysis of this multicentre double-blind randomized phase II clinical study was performed on 40 patients with progressive corneal neovascularisation due to different underlying diseases: 4 groups of 10 patients were treated in the dose finding study comparing 3 doses of GS-101 to placebo eye drops.